KemPharm
KMPH
$5.81
Share price
-0.34%
Change (1 day)
6.61%
Change (1 year)
Categories
KemPharm (KMPH) - Net assets
Net assets on the balance sheet as of December 2022 : $85.8 M
According to KemPharm's latest financial reports the company has $85.8 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
KemPharm - Net assets on balance sheet (from 2014 to 2022)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $85.8 M | -32.5% |
| 2021-12-31 | $0.12 B | -291.41% |
| 2020-12-31 | $-66.42 M | -10.8% |
| 2019-12-31 | $-74.46 M | 11.85% |
| 2018-12-31 | $-66.57 M | 15.73% |
| 2017-12-31 | $-57.52 M | 207.64% |
| 2016-12-31 | $-18.7 M | 84.72% |
| 2015-12-31 | $-10.13 M | -58.35% |
| 2014-12-31 | $-24.31 M | 0.14% |
| 2013-12-31 | $-24.27 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Theravance Biopharma
TBPH | $0.21 B | 148.23% | Cayman Islands |
 Jazz Pharmaceuticals JAZZ | $3.69 B | 4,207.88% | 🇮🇪 Ireland |
 ANI Pharmaceuticals ANIP | $0.45 B | 433.29% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -$16.32 M | -119.02% | 🇺🇸 USA |